|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
WO1999065867A1
(en)
|
1998-06-17 |
1999-12-23 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
PT1177176E
(pt)
|
1999-04-28 |
2006-08-31 |
Aventis Pharma Gmbh |
Derivados de acidos triarilicos como ligandos de receptores ppar.
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
JP3486408B2
(ja)
|
1999-08-23 |
2004-01-13 |
株式会社ビー・エム・エル |
物質のヒトプロスタグランジンｄ２受容体に対する性質の同定方法
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
ATE340796T1
(de)
|
2001-05-23 |
2006-10-15 |
Merck Frosst Canada Inc |
Dihydropyrrolo(1,2-aöindol- und tetrahydropyrido)1,2-aöindolderivate als prostaglandin rezeptor antagonisten
|
|
CA2452391A1
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
US6869975B2
(en)
*
|
2001-09-14 |
2005-03-22 |
Tularik Inc. |
Linked biaryl compounds
|
|
BR0315681A
(pt)
|
2002-10-30 |
2005-09-06 |
Merck Frosst Canada Inc |
Composto e seus sais e hidratos farmaceuticamente aceitáveis, composição farmacêutica, métodos para o tratamento de doenças mediadas pela prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, composto ou um seu sal ou solvato farmaceuticamente aceitável, sal ou hidrato do composto, e, uso de um composto ou de um seu sal ou solvato farmaceuticamente aceitável
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
NZ541234A
(en)
|
2002-12-20 |
2008-06-30 |
Amgen Inc |
Asthma and allergic inflammation modulators
|
|
ES2257616T3
(es)
|
2003-04-25 |
2006-08-01 |
Actimis Pharmaceuticals, Inc. |
Derivados del acido pirimidinilacetico utiles para el tratamiento de enfermedades mediadas por crth2.
|
|
JP2007508363A
(ja)
|
2003-10-14 |
2007-04-05 |
オキサジェン リミテッド |
Ｃｒｔｈ２アンタゴニスト活性を有する化合物
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
EP1688138A4
(en)
|
2003-11-26 |
2008-01-16 |
Takeda Pharmaceutical |
RECEPTOR FUNCTIONAL REGULATING MEANS
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
US7737295B2
(en)
|
2004-04-13 |
2010-06-15 |
Merck Sharp & Dohme Corp. |
CETP inhibitors
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
RU2007109778A
(ru)
|
2004-08-17 |
2008-09-27 |
Галдерма Ресерч Энд Девелопмент, С.Н.С. (Fr) |
Новые биароматические соединения, которые активируют рецепторы типа ppar, и их применение в косметических и фармацевтических композициях
|
|
JP2008513512A
(ja)
|
2004-09-21 |
2008-05-01 |
アサーシス， インク． |
Ｃｒｔｈ２受容体拮抗作用を示すインドール酢酸およびこれらの使用
|
|
WO2006034418A2
(en)
|
2004-09-21 |
2006-03-30 |
Athersys, Inc. |
Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
CA2589322A1
(en)
|
2004-11-23 |
2006-06-01 |
Pfizer Products Inc. |
Dibenzyl amine compounds and derivatives
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
WO2007037187A1
(ja)
|
2005-09-27 |
2007-04-05 |
Shionogi & Co., Ltd. |
Ｐｇｄ２受容体アンタゴニスト活性を有するスルホンアミド誘導体
|
|
WO2007039736A1
(en)
|
2005-10-06 |
2007-04-12 |
Astrazeneca Ab |
Novel compounds
|
|
WO2007068894A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Astrazeneca Ab |
Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
|
|
EP1976828B1
(en)
|
2005-12-29 |
2016-12-21 |
Celtaxsys, Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
WO2007146838A2
(en)
*
|
2006-06-09 |
2007-12-21 |
Icos Corporation |
Substituted phenyl acetic acids as dp-2 antagonists
|
|
SG174069A1
(en)
*
|
2006-08-21 |
2011-09-29 |
Array Biopharma Inc |
4-substituted phenoxyphenylacetic acid derivatives
|
|
CA2934114A1
(en)
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
CA2691662A1
(en)
|
2007-07-02 |
2009-01-08 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as ccr2 receptor antagonists
|
|
MX2010003621A
(es)
|
2007-10-01 |
2010-04-14 |
Hoffmann La Roche |
N-heterociclil biaril carboxamidas como antagonistas del receptor ccr.
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
RS53142B
(sr)
|
2008-01-18 |
2014-06-30 |
Atopix Therapeutics Limited |
Jedinjenja koja imaju antagonističku aktivnost na crth2
|
|
CA2713139C
(en)
|
2008-02-01 |
2013-04-23 |
Amira Pharmaceuticals, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
UA98839C2
(en)
|
2008-02-01 |
2012-06-25 |
Панмира Фармасьютикалз, Ллк. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
US8426449B2
(en)
*
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
CA2729292C
(en)
|
2008-07-03 |
2013-09-03 |
Amira Pharmaceuticals, Inc. |
Phenoxyphenyl sulfide, sulfinyl and sulfonyl antagonists of prostaglandin d2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
CN102596193A
(zh)
|
2009-07-31 |
2012-07-18 |
潘米拉制药公司 |
Dp2受体拮抗的皮肤调配物
|
|
WO2011014587A2
(en)
|
2009-07-31 |
2011-02-03 |
Amira Pharmaceuticals, Inc. |
Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
|